Protein Sequencing Market Expected to Reach US$ 1.79 Billion by 2031 | Growth Plus Reports

Newark, New Castle, USA, April 06, 2023 (GLOBE NEWSWIRE) — According to a recent report by Growth Plus Reports, the global protein sequencing market was valued at US$ 1.32 billion in 2023 and is expected to surpass US$ 1.79 billion by 2031, at a revenue CAGR of 3.40%. The report analyzes top winning strategies, drivers & opportunities, competitive scenarios, wavering market trends, market size, statistics & estimations, and major investment pockets.

Key Takeaways:

• The increasing requirement for protein biomarkers in drug development will provide plenty of growth opportunities for the protein sequencing market.
• North America will dominate the global protein sequencing market.
• Increasing funding for research will fuel the growth of the protein sequencing market.

Request a Free Sample PDF: https://www.growthplusreports.com/inquiry/request-sample/protein-sequencing-market/8506

                                     Protein Sequencing Market Scope

Market Drivers

The growing focus of biotechnology and pharmaceutical companies on target-based drug research activities is the primary factor driving the revenue growth of the global market. Furthermore, increased funding for proteomics research, advancements in de novo protein-sequencing technologies and analytical methods, and the requirement for protein biomarkers in drug development will support market revenue growth.

Market Segmentation

Growth Plus Reports has analyzed the global protein sequencing market from three perspectives: Product, Application, End-users, and Region.

Product Segmentation: Based on the product, the global protein sequencing market is segmented into protein sequencing products and protein sequencing services. The protein sequencing products segment dominates the market with the largest revenue share because they have a number of benefits, including the capacity for high-tech protein sequencing, affordability, and the ability to find proteins that have been inhibited or altered.

Application Segmentation: Based on the application, the global protein sequencing market is segmented into bio-therapeutics, genetic engineering, and others. The bio-therapeutics segment dominates the market with the largest revenue share because as they are frequently used in personalized medicine, where therapies are adapted to each patient’s specific needs.

End-Users Segmentation: Based on the end-users, the global protein sequencing market is segmented into academic institutes & research centres, pharmaceutical & biotechnology companies, and others. The academic institutes & research centres segment dominates the market with the largest revenue share because they have the money and means to purchase cutting-edge tools and facilities that enable them to carry out cutting-edge research.

Regional Growth Dynamics

Based on the region, the global protein sequencing market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America dominates the global protein sequencing market due to the increased funding for proteomic research, the existence of major industry players, an increase in the prevalence of chronic diseases, a rise in the number of elderly people, a rising demand for protein sequencing, and advanced healthcare infrastructure.

Request for Customization – https://www.growthplusreports.com/inquiry/customization/protein-sequencing-market/8506

Competitive Landscape

The major players operating in the global protein sequencing market are:

• Nihon Kohden Corporation
• Thermo Fisher Scientific Inc.
• Shimadzu Corporation
• Agilent Technologies Inc.
• Rapid Novor Inc.
• Charles River Laboratories
• Proteome Factory AG
• Selvita S.A.
• Bioinformatics Solutions Inc.
• Creative Proteomics
• Alphalyse Inc.
• Bruker Corporation

The protein sequencing market is moderately competitive with few key players. Key players operating in the market are implementing competitive sustainability tactics such as product development and regional presence growth. Major firms are aggressively acquiring other companies to strengthen their global market positions.

Recent developments:

• Quantum-Si introduced the “Platinum” innovation for benchtop protein sequencing in December 2022. The next generation of single-molecule protein sequencing is made possible by platinum. Through proteome research, the method may improve drug development and medical diagnostics.
• NVIDIA Corporation stated in September 2022 that its NeMo LLM cloud service would be integrated with BioNeMO, providing researchers access to pre-trained chemical and biology language models. These services support data, protein, and research interaction for a range of objectives, including drug development.

Table of Content

1. INTRODUCTION
   1. Market Ecosystem 
   2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
   4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions       
3. PREMIUM INSIGHTS
   1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2022)
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints
   3. Opportunities
5. GLOBAL PROTEIN SEQUENCING MARKET- ANALYSIS & FORECAST, BY PRODUCT & SERVICES
   1. Protein Sequencing Products
      1. Reagents & Consumables
      2. Instruments
         1. Mass Spectrometry Instruments
         2. Edman Degradation Sequencers
      3. Software
   2. Protein Sequencing Services
6. GLOBAL PROTEIN SEQUENCING MARKET- ANALYSIS & FORECAST, BY APPLICATION
   1. Bio-therapeutics
   2. Genetic Engineering
   3. Others
7. GLOBAL PROTEIN SEQUENCING MARKET- ANALYSIS & FORECAST, BY END USER
   1. Academic Institutes & Research Centers
   2. Pharmaceutical & Biotechnology Companies
   3. Others

PROTEIN SEQUENCING MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8506

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• ‘Business Profile’ of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at – https://www.growthplusreports.com/report-store

Browse Latest Healthcare Related Reports:

Chemotherapy Devices Market by Product Type (Catheters, Cannulas, Infusion Pumps), End User (Hospitals, Homecare Settings)-Global Outlook & Forecast 2023-2031

Cell Culture Reagents Market by Product (Supplements, Cryoprotective Reagents) Application (Bioproduction, Diagnostics, Cancer Research), End User (Pharmaceutical & Biotechnology Companies) – Global Outlook & Forecast 2022-2023

Cell and Gene Therapy Manufacturing Services Market by Type (Cell Therapy, Gene Therapy), Indication (Oncology Diseases, Cardiovascular Diseases), End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes) – Global Outlook and Forecast 2023-2031

Alveolar Soft Part Sarcoma Market by Type (Monotherapy, Combination Therapy), Therapy (Chemotherapy, Targeted Therapy), End User (Hospitals, Cancer Speciality Centers) – Global Outlook and Forecast 2023-2031

UV Infection Control Devices Market by Type (Mobile, Stationary), End User (Hospital, Specialty Clinics) – Global Outlook & Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.